Quick Answer
Radiopharm Theranostics Ltd reported Gross Profit of $39.3 thousand for the year ending 2025.
- Radiopharm Theranostics Ltd showed a decrease of -86.9% in Gross Profit from 2024 to 2025.
- This data is from Radiopharm Theranostics Ltd's annual report (Form 10-K), filed with the SEC on September 18, 2025.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 3 years of available data (2023 to 2025), Radiopharm Theranostics Ltd's Gross Profit has declined by 86.6%.
- Historical annual values: Fiscal year 2025: $39.3 thousand | Fiscal year 2024: $299.2 thousand | Fiscal year 2023: $292.4 thousand.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: